SynCore Biotechnology Co

SynCore Biotechnology Co DSCR

The Debt Service Coverage Ratio (DSCR) of SynCore Biotechnology Co (4192.TWO) as of Oct 17, 2026 is -38.97. In the previous year, Debt Service Coverage Ratio (DSCR) was -2.92 — a change of 1,233.95% (lower).

DSCR

-38.97

YoY

1,233.95%

Last updated:

Debt Service Coverage Ratio (DSCR) of SynCore Biotechnology Co is 2023 -38.97 . Debt Service Coverage Ratio (DSCR) of SynCore Biotechnology Co was 2022 -2.92 . It decreases by 1,233.95% lower compared to the previous year.

The SynCore Biotechnology Co DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2016
-5.66 TWD
Jan 1, 2017
-5.62 TWD
Jan 1, 2018
-7.69 TWD
Jan 1, 2019
-5.66 TWD
Jan 1, 2020
-1.38 TWD
Jan 1, 2021
-1.83 TWD
Jan 1, 2022
-2.92 TWD
Jan 1, 2023
-38.97 TWD
The SynCore Biotechnology Co DSCR history
YEARDSCRYoY
-38.97+1,233.95%
-2.92+59.43%
-1.83+32.41%
-1.38-75.54%
-5.66-26.47%
-7.69+36.79%
-5.62-0.71%
-5.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SynCore Biotechnology Co Stock analysis

What does SynCore Biotechnology Co do? SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan. SynCore Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SynCore Biotechnology Co stock

Debt Service Coverage Ratio (DSCR) of SynCore Biotechnology Co is -38.97 in 2023.

Debt Service Coverage Ratio (DSCR) of SynCore Biotechnology Co changed from -2.92 to -38.97, representing a 1,233.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s SynCore Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — SynCore Biotechnology Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — SynCore Biotechnology Co